Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis?

E. Besada, Hans Nossent

Research output: Contribution to journal › Review article

28 Citations (Scopus)

Original language	English
Pages (from-to)	1677-1681
Journal	Clinical Rheumatology
Volume	32
Issue number	11
DOIs	https://doi.org/10.1007/s10067-013-2293-4
Publication status	Published - 2013

Access to Document

10.1007/s10067-013-2293-4

Cite this

@article{3e1a94151d094d48a299366a64779d52,

title = "Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis?",

author = "E. Besada and Hans Nossent",

year = "2013",

doi = "10.1007/s10067-013-2293-4",

language = "English",

volume = "32",

pages = "1677--1681",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "Springer",

number = "11",

}

TY - JOUR

T1 - Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis?

AU - Besada, E.

AU - Nossent, Hans

PY - 2013

Y1 - 2013

U2 - 10.1007/s10067-013-2293-4

DO - 10.1007/s10067-013-2293-4

M3 - Review article

C2 - 23754241

SN - 0770-3198

VL - 32

SP - 1677

EP - 1681

JO - Clinical Rheumatology

JF - Clinical Rheumatology

IS - 11

ER -